Skip to the page

Data / Form D filings / ATROPOS HEALTH INC

ATROPOS HEALTH INC: Form D filings

ATROPOS HEALTH INC, a health care company in New York, NY, filed 3 Form D notices with the SEC between 2022 and 2024. The latest, on May 31, 2024, reports $33 million sold of a $33 million offering to 7 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
169 MADISON AVENUE, SUITE 2242, New York, NY, 10016
Phone
(646) 850-6610
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2019
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1943427

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
May 31, 2024New notice$33,000,000$32,999,989$117May 20, 2024sec.gov
Aug 11, 2023New notice$5,000,000$3,325,314$1,674,6868Jul 28, 2023sec.gov
Aug 18, 2022New notice$8,000,000$8,000,00016Aug 4, 2022sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Neil SanghaviExecutive Officer
Nigam ShahDirector
Matthew BettonvilleDirector
Mike SpadaforeDirector
Brigham HydeExecutive Officer, Director
Saurabh GombarExecutive Officer

Other health care companies in New York that filed recently

Every Form D from the week of May 27, 2024 · All recent filings in New York · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what ATROPOS HEALTH INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.